Michelle has extensive experience in evaluation and treatment of neuromuscular and neurological indications. Prior to PepGen, she served in roles of increasing responsibility at Fulcrum Therapeutics, where she led the design and implementation of clinical trials for the company’s treatment of facioscapulohumeral muscular dystrophy. While leading clinical development efforts at Fulcrum, she also worked as an attending physician affiliated with Tufts Medical Center, specializing in the treatment of neurological and neuromuscular disorders. Michelle has also held leadership roles at Vertex Pharmaceuticals and Biogen and was an attending neurologist in the Muscular Dystrophy Association (MDA) clinic and attending physician and assistant professor of neurology at Alpert Medical School, Brown University. Michelle completed her residency at Brown Medical School, received her M.D. from the Wake Forest University School of Medicine, and earned her B.A. in molecular biology from Colgate University.